Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.
about
Ductal approaches to assessment and management of women at high risk for developing breast cancerThe utility of ductal lavage in breast cancer detection and risk assessmentCytologic features of nipple aspirate fluid using an automated non-invasive collection device: a prospective observational studyPatterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancerAssociation of kallikrein expression in nipple aspirate fluid with breast cancer riskNipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsyA unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient.Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women.uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy.Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controlsBreast cancer biomarkers predict weight loss after gastric bypass surgery.Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy.Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women.Nipple aspiration in diagnosis of breast cancer.Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary.Lavage and nipple aspiration of breast ductal fluids: a source of biomarkers for environmental mutagenesis.Chemoprevention of breast cancer: implications for postmenopausal women.Paired ductal carcinoma in situ and invasive breast cancer lesions in the D-loop of the mitochondrial genome indicate a cancerization field effect.Black cohosh does not exert an estrogenic effect on the breast.Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS.Protein identification from dried nipple aspirate fluid on Guthrie cards using mass spectrometry.Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter studyThe role of ductal lavage in the management of women at high risk for breast carcinoma.CEA in breast ductal secretions as a promising biomarker for the diagnosis of breast cancer: a systematic review and meta-analysis.The role of nipple discharge cytology in the diagnosis of breast disease: a study of 1948 nipple discharge smears from 1530 patients.Identification of a beta-casein-like peptide in breast nipple aspirate fluid that is associated with breast cancer.Nipple aspirate fluid and ductoscopy to detect breast cancerSoy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal womenQuantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids.Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast CancerAnalysis of nipple aspirate fluid for diagnosis of breast cancer: an alternative to invasive biopsy.Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.Nutrients and nipple aspirate fluid composition: the breast microenvironment regulates protein expression and cancer aetiology.Mass spectrometry-based "omics" technologies in cancer diagnostics.
P2860
Q24794407-94134486-EB5C-49D6-8A54-545874D00E26Q24802209-058F9FF1-897C-47EE-9676-ED86FF100C75Q24810757-F403AC5A-F5AB-4DA7-948F-0BA8C22A20F9Q25257326-91CD3947-650E-4309-8F5B-1B7A96207F53Q25257803-2ABAF023-273F-4267-B113-A3B8D5B50156Q28200802-F50D70E3-402B-4C3C-A99C-4D58903167ECQ28236233-3E745860-6855-428F-B651-3F97098ECF1EQ28366580-11A26716-E786-4A77-9645-2BE782F7363CQ30879733-C8D794AF-318A-4965-90FF-55C970B86AC1Q33210185-E7C5E000-D707-4E1F-9AE6-1E83BFC4F2D4Q33236750-F6530068-746A-4CA8-9374-A8C0875053BEQ33319315-B4203B20-827C-4127-8D54-DE560C6D8E87Q33376876-5E460833-7C78-4B6D-9B34-F80015E44808Q33710073-6142CD4F-BBE0-4D16-8C3B-DBB7A5EC4638Q33913866-2EB82EFD-38ED-4573-8184-761393021F47Q34147149-7374D279-5B48-4BC0-ACC0-58FB78A4DB0DQ34148127-49CB0617-DEF0-4857-9348-F8F3B8FD9841Q34256185-05B18BDC-C8A8-41EF-8804-C569F9F73EC1Q34346837-400D1BE0-BE63-4715-AD92-54CE8087ABD4Q34497398-133938D3-D459-4D91-913C-E91F12F6E26DQ34568124-9B09DB87-5C51-4E3D-A23B-A06A70BE5E6AQ34580698-2E80624B-523F-4B3D-B4EC-65C039753606Q34585121-4C1E2A5A-4D86-40E6-B2E0-5CF0BC316F26Q34627310-3199E26F-35EA-4F67-8761-A06D1EA7F74BQ34713601-31D04B0C-890F-47E5-84DC-FD7F9460DA46Q35581163-6D96CEB2-4D1B-425B-A6C8-04F85AEE2B61Q35628469-9FEA9D1D-9DC7-49DA-9C17-D4EDE40F407FQ35637243-86E71AE0-0FAA-4098-9B3D-903BD751B6ABQ35678131-111DBF30-D708-4745-A580-C2AF3645E07FQ35929665-A06B795F-7A83-4F86-9C60-8A66FEA24756Q35987825-D5584DA0-2FEC-41AD-9F45-E01A80B0D2CCQ36039044-7094C649-0193-4213-97C1-081622E25381Q36079196-9E83BEC1-F718-4F44-9F9D-762325AC204DQ36079644-3943B4F7-5BA2-49B3-8773-B58F61C61F77Q36100208-4B4ADA24-33C4-4564-95C3-66C85FEB228BQ36133631-A618124B-DE88-4479-A56C-77E941570905Q36299899-1EA9E140-987F-4691-AB76-4DA935A12B7DQ36641088-9AEAC3C6-B081-4E59-A0FD-9B905D93EC55Q36772378-3B9433A2-7F5F-40E2-9837-17250024C8CBQ36778885-A771CFA2-9F24-4F12-AD16-935A0A490CD4
P2860
Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Nipple aspirate fluid: a promi ...... markers of breast cancer risk.
@ast
Nipple aspirate fluid: a promi ...... markers of breast cancer risk.
@en
type
label
Nipple aspirate fluid: a promi ...... markers of breast cancer risk.
@ast
Nipple aspirate fluid: a promi ...... markers of breast cancer risk.
@en
prefLabel
Nipple aspirate fluid: a promi ...... markers of breast cancer risk.
@ast
Nipple aspirate fluid: a promi ...... markers of breast cancer risk.
@en
P2093
P2860
P356
P1476
Nipple aspirate fluid: a promi ...... markers of breast cancer risk.
@en
P2093
Engstrom PF
Klein-Szanto A
P2860
P2888
P304
P356
10.1038/BJC.1997.415
P407
P577
1997-01-01T00:00:00Z